1. From molecular pathogenesis to therapy: Unraveling non-coding RNAs/DNMT3A axis in human cancers
   Chunjie Huang et al, 2024, Biochemical Pharmacology CrossRef
2. MiR-532-3pinhibited the methylation ofSOCS2to suppress the progression of PC by targetingDNMT3A
   Kaiqiong Wang et al, 2023, Life Science Alliance CrossRef
3. Profound changes in miRNA expression during cancer initiation by aflatoxin B1 and their abrogation by the chemopreventive triterpenoid CDDO‐Im
   Merricka C. Livingstone et al, 2017, Molecular Carcinogenesis CrossRef
4. DNA and Histone Methylation in Liver Cancer
   Eri Arai et al, 2017, DNA and Histone Methylation as Cancer Targets CrossRef
5. Exosomal MicroRNA-126 from RIPC Serum Is Involved in Hypoxia Tolerance in SH-SY5Y Cells by Downregulating DNMT3B
   Junhe Cui et al, 2020, Molecular Therapy - Nucleic Acids CrossRef
6. MicroRNA-30a suppresses tumor progression by blocking Ras/Raf/MEK/ERK signaling pathway in hepatocellular carcinoma
   Kun Zhou et al, 2017, Biomedicine & Pharmacotherapy CrossRef
7. Cardiac repair in a mouse model of acute myocardial infarction with trophoblast stem cells
   Guannan Li et al, 2017, Scientific Reports CrossRef
8. MicroRNA dysregulation interplay with childhood abdominal tumors
   Karina Bezerra Salomão et al, 2019, Cancer and Metastasis Reviews CrossRef
9. Serum miR‐182 is a predictive biomarker for dichotomization of risk of hepatocellular carcinoma in rats
   Merricka C. Livingstone et al, 2019, Molecular Carcinogenesis CrossRef
10. Mechanisms and Functions of MiR-200 Family in Hepatocellular Carcinoma
    Yinqi Mao et al, 2021, OncoTargets and Therapy CrossRef
11. Upregulation of miR-200b Inhibits Hepatocellular Carcinoma Cell Proliferation and Migration by Targeting HMGB3 Protein
    Long-kun Wang et al, 2018, Technology in Cancer Research & Treatment CrossRef
12. The mechanistic, diagnostic and therapeutic novel nucleic acids for hepatocellular carcinoma emerging in past score years
    Song Zhang et al, 2021, Briefings in Bioinformatics CrossRef
13. MiR-30b-5p acts as a tumor suppressor, repressing cell proliferation and cell cycle in human hepatocellular carcinoma
    Xian Qin et al, 2017, Biomedicine & Pharmacotherapy CrossRef
14. miR‑30a‑3p inhibits the proliferation of liver cancer cells by targeting DNMT3a through the PI3K/AKT signaling pathway
    Qiong Chen et al, 2019, Oncology Letters CrossRef
15. MicroRNA-296-5p downregulated AKT2 to inhibit hepatocellular carcinoma cell proliferation, migration and invasion
    Xiaojun Ma et al, 2017, Molecular Medicine Reports CrossRef
16. Regulation of DNA methylation machinery by epi-miRNAs in human cancer: emerging new targets in cancer therapy
    Mohammad Reza Karimzadeh et al, 2021, Cancer Gene Therapy CrossRef